Not Tagged
ucb pharmaceuticals
['axspa', ' psa', 'ucb_news']
should you be aiming higher for patients with psa and axspa? meet our panel of esteemed experts, led by our chair francesco ciccia, who ll reveal the benefits of high treatment targets during the ucb eular european congress of rheumatology 2023 industry satellite symposium.
A global biopharma company focusing on creating value for people living with neurology and immunology diseases. 
We are inspired by patients, driven by science.